Finance

Lists
2005:HKG
SSY Group Ltd
HK$2.73
-0.18%
(-0.0050) 1D
Sep 4, 4:08:01 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2005...
Open
HK$2.74
High
HK$2.77
Low
HK$2.72
Mkt. cap
7.89B
Avg. vol.
0.00
Volume
3.50M
Dividend
3.11%
Quarterly dividend
HK$0.02
Ex-dividend date
May 20, 2026
P/E ratio
15.62
52-wk high
HK$3.40
52-wk low
HK$2.01
EPS
HK$0.17
Shares outstanding
2.95B
No. of employees
5K
Open
HK$2.74
High
HK$2.77
Low
HK$2.72
Mkt. cap
7.89B
Avg. vol.
0.00
Volume
3.50M
Dividend
3.11%
Quarterly dividend
HK$0.02
Ex-dividend date
May 20, 2026
P/E ratio
15.62
52-wk high
HK$3.40
52-wk low
HK$2.01
EPS
HK$0.17
Shares outstanding
2.95B
No. of employees
5K
Profile
Lijun International Pharmaceutical (Holding) Co., Limited is a Wanchai, Hong Kong–based investment holding company with two pharmaceutical business segments: Wikipedia
About SSY Group Ltd
CEO-
Employees5.4K
Founded1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HKD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.01B
1.01B
1.18B
1.18B
Cost of goods sold
588.81M
588.81M
694.08M
694.08M
Cost of revenue
588.81M
588.81M
694.08M
694.08M
Research and development expenses
53.89M
53.89M
48.48M
48.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
296.21M
296.21M
238.84M
238.84M
Operating expense
308.00M
308.00M
263.56M
263.56M
Total operating expenses
896.81M
896.81M
957.64M
957.64M
Operating income
112.33M
112.33M
222.65M
222.65M
Other non operating income
-526.00K
-526.00K
-
-
EBT including unusual items
107.30M
107.30M
193.72M
193.72M
EBT excluding unusual items
90.07M
90.07M
193.72M
193.72M
Income tax expense
10.66M
10.66M
30.42M
30.42M
Effective tax rate
9.94%
9.94%
15.70%
15.70%
Other operating expenses
-40.25M
-40.25M
-27.91M
-27.91M
Net income
93.56M
93.56M
160.16M
160.16M
Net profit margin
9.27%
9.27%
13.57%
13.57%
Earnings per share
-
-
-
-
Interest and investment income
3.85M
3.85M
4.31M
4.31M
Interest expense
-25.39M
-25.39M
-25.98M
-25.98M
Net interest expenses
-21.54M
-21.54M
-21.67M
-21.67M
Depreciation and amortization charges
-
-
-
-
EBITDA
219.31M
219.31M
332.61M
332.61M
Gain or loss from assets sale
9.01M
9.01M
-
-
AI content may include mistakes. Learn more
Google apps